| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1164196S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0164196 |
| P932 | PMC publication ID | 5068821 |
| P698 | PubMed publication ID | 27755546 |
| P50 | author | Johan Trygg | Q88000623 |
| Solbritt Rantapää-Dahlqvist | Q30501391 | ||
| P2093 | author name string | Izabella Surowiec | |
| Lisbeth Ärlestig | |||
| P2860 | cites work | Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. | Q51554421 |
| Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. | Q53021020 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Hypoxanthine as a Measurement of Hypoxia | Q58144110 | ||
| Chylomicron metabolism is markedly altered in systemic lupus erythematosus | Q61974594 | ||
| Autoimmune inflammation from the Th17 perspective | Q79749411 | ||
| Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells | Q80079006 | ||
| G2A and LPC: regulatory functions in immunity | Q37339837 | ||
| The impact of inflammation on metabolomic profiles in patients with arthritis | Q37343272 | ||
| Metabolism and atherogenic disease association of lysophosphatidylcholine | Q37537825 | ||
| Metabolism of inflammation limited by AMPK and pseudo-starvation | Q38074586 | ||
| Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis | Q38127176 | ||
| Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme | Q38216608 | ||
| Cardiovascular comorbidity in rheumatic diseases | Q38568465 | ||
| Preclinical Rheumatoid Arthritis: Progress Toward Prevention | Q38712937 | ||
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
| 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. | Q42940729 | ||
| Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis | Q44455056 | ||
| Increased degradation of tryptophan in blood of patients with rheumatoid arthritis | Q44579743 | ||
| Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis | Q44616885 | ||
| Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment | Q44943883 | ||
| Metabolic responses to change in disease activity during tumor necrosis factor inhibition in patients with rheumatoid arthritis | Q45733308 | ||
| Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. | Q46030942 | ||
| Tryptophan degradation increases with stage in patients with rheumatoid arthritis | Q46784340 | ||
| Atherosclerosis | Q24644573 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Lysophospholipids--receptor revelations | Q28208260 | ||
| Therapeutic effects of lysophosphatidylcholine in experimental sepsis | Q28238163 | ||
| Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism | Q28271624 | ||
| Hypoxanthine, xanthine, and urate in synovial fluid from patients with inflammatory arthritides | Q28334009 | ||
| A fast method for the determination of the PC/LPC ratio in intact serum by MALDI-TOF MS: an easy-to-follow lipid biomarker of inflammation. | Q30836173 | ||
| The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. | Q33220323 | ||
| Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis | Q33699851 | ||
| Lysophospholipid receptors | Q34192747 | ||
| Unfolding the pathophysiological role of bioactive lysophospholipids | Q35061032 | ||
| Tryptophan and the immune response | Q35171881 | ||
| Diagnostic properties of metabolic perturbations in rheumatoid arthritis | Q35620317 | ||
| Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis | Q35636947 | ||
| Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis | Q35638659 | ||
| Monitoring tryptophan metabolism in chronic immune activation | Q36247653 | ||
| Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis | Q36348728 | ||
| Emerging medicinal roles for lysophospholipid signaling | Q36366021 | ||
| Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice | Q36392296 | ||
| Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis | Q36577538 | ||
| New developments in the biological functions of lysophospholipids | Q36599952 | ||
| Lysophospholipid receptors in cell signaling | Q36762479 | ||
| Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis | Q37023883 | ||
| Fatty acids as modulators of the cellular production of reactive oxygen species | Q37164853 | ||
| Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. | Q37185895 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| biobank | Q864217 | ||
| P304 | page(s) | e0164196 | |
| P577 | publication date | 2016-10-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis | |
| P478 | volume | 11 |
| Q64885761 | Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis? |
| Q92876537 | Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases |
| Q50016514 | LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis |
| Q48285032 | Medium- and long-chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end-stage osteoarthritis patients: a case-control study |
| Q91796785 | Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis |
| Q59798416 | Multi-omic analysis of signalling factors in inflammatory comorbidities |
| Q92017382 | Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis |
Search more.